NRC Health Excess Tax Benefit from Share-based Compensation, Financing Activities
NRC Health (NRC) reported Excess Tax Benefit from Share-based Compensation, Financing Activities of $333.00 thousand for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-06.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2018-03-14
- NRC Health excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-03-31 was $333.00K, a 254.26% increase year-over-year.
- NRC Health excess tax benefit from share-based compensation, financing activities for the quarter ending 2015-12-31 was $133.00K, a 46.15% increase year-over-year.
- NRC Health excess tax benefit from share-based compensation, financing activities for the quarter ending 2015-09-30 was $7.00K.
- NRC Health excess tax benefit from share-based compensation, financing activities for the quarter ending 2015-06-30 was $6.00K, a 100.00% increase year-over-year.
- NRC Health excess tax benefit from share-based compensation, financing activities for fiscal 2015 was $240.00K, a 61.41% decline from fiscal 2014.
- NRC Health excess tax benefit from share-based compensation, financing activities for fiscal 2014 was $622.00K, a 17.62% decline from fiscal 2013.
- NRC Health excess tax benefit from share-based compensation, financing activities for fiscal 2013 was $755.00K, a 63.67% decline from fiscal 2012.
- NRC Health excess tax benefit from share-based compensation, financing activities for fiscal 2012 was $2.08M, a 410.57% increase from fiscal 2011.
| Period end | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 9 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month |
|---|---|---|---|---|
| 2016-03-31 | $333.00K 10-Q · filed 2016-05-06 | $466.00K derived: sum of 2 quarters · filed 2018-03-14 | $473.00K derived: sum of 3 quarters · filed 2018-03-14 | $479.00K derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $140.00K derived: sum of 2 quarters · filed 2018-03-14 | $146.00K derived: sum of 3 quarters · filed 2018-03-14 | $240.00K 10-K · filed 2018-03-14 |
| 2015-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $13.00K derived: sum of 2 quarters · filed 2016-11-04 | $107.00K 10-Q · filed 2016-11-04 | $198.00K derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $100.00K 10-Q · filed 2016-08-05 | $191.00K derived: sum of 3 quarters · filed 2017-03-03 | $191.00K derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-03-31 | $94.00K 10-Q · filed 2016-05-06 | $185.00K derived: sum of 2 quarters · filed 2017-03-03 | $185.00K derived: sum of 3 quarters · filed 2017-03-03 | $188.00K derived: sum of 4 quarters · filed 2017-03-03 |
| 2014-12-31 | $91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $91.00K derived: sum of 2 quarters · filed 2017-03-03 | $94.00K derived: sum of 3 quarters · filed 2017-03-03 | $622.00K 10-K · filed 2017-03-03 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $3.00K derived: sum of 2 quarters · filed 2015-11-05 | $531.00K 10-Q · filed 2015-11-05 | $711.00K derived: sum of 4 quarters · filed 2016-03-04 |
| 2014-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $531.00K 10-Q · filed 2015-08-06 | $711.00K derived: sum of 3 quarters · filed 2016-03-04 | $711.00K derived: sum of 4 quarters · filed 2016-03-04 |
| 2014-03-31 | $528.00K 10-Q · filed 2015-05-08 | $708.00K derived: sum of 2 quarters · filed 2016-03-04 | $708.00K derived: sum of 3 quarters · filed 2016-03-04 | $708.00K derived: sum of 4 quarters · filed 2016-03-04 |
| 2013-12-31 | $180.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | $180.00K derived: sum of 2 quarters · filed 2016-03-04 | $180.00K derived: sum of 3 quarters · filed 2016-03-04 | $755.00K 10-K · filed 2016-03-04 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $0.00 derived: sum of 2 quarters · filed 2014-11-07 | $575.00K 10-Q · filed 2014-11-07 | $1.30M derived: sum of 4 quarters · filed 2015-03-04 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $575.00K 10-Q · filed 2014-08-06 | $1.30M derived: sum of 3 quarters · filed 2015-03-04 | $1.75M derived: sum of 4 quarters · filed 2015-03-04 |
| 2013-03-31 | $575.00K 10-Q · filed 2014-05-08 | $1.30M derived: sum of 2 quarters · filed 2015-03-04 | $1.75M derived: sum of 3 quarters · filed 2015-03-04 | $2.05M derived: sum of 4 quarters · filed 2015-03-04 |
| 2012-12-31 | $725.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-04 | $1.18M derived: sum of 2 quarters · filed 2015-03-04 | $1.48M derived: sum of 3 quarters · filed 2015-03-04 | $2.08M 10-K · filed 2015-03-04 |
| 2012-09-30 | $454.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $754.00K derived: sum of 2 quarters · filed 2013-11-07 | $1.35M 10-Q · filed 2013-11-07 | $1.41M derived: sum of 4 quarters · filed 2014-03-04 |
| 2012-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $899.00K 10-Q · filed 2013-08-08 | $952.00K derived: sum of 3 quarters · filed 2014-03-04 | $1.11M derived: sum of 4 quarters · filed 2014-03-04 |
| 2012-03-31 | $599.00K 10-Q · filed 2013-05-08 | $652.00K derived: sum of 2 quarters · filed 2014-03-04 | $810.00K derived: sum of 3 quarters · filed 2014-03-04 | $935.00K derived: sum of 4 quarters · filed 2014-03-04 |
| 2011-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04 | $211.00K derived: sum of 2 quarters · filed 2014-03-04 | $336.00K derived: sum of 3 quarters · filed 2014-03-04 | $407.00K 10-K · filed 2014-03-04 |
| 2011-09-30 | $158.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $283.00K derived: sum of 2 quarters · filed 2012-11-07 | $354.00K 10-Q · filed 2012-11-07 | $380.00K derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $196.00K 10-Q · filed 2012-08-10 | $222.00K derived: sum of 3 quarters · filed 2013-03-01 | $237.00K derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $71.00K 10-Q · filed 2012-05-11 | $97.00K derived: sum of 2 quarters · filed 2013-03-01 | $112.00K derived: sum of 3 quarters · filed 2013-03-01 | |
| 2010-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $41.00K derived: sum of 2 quarters · filed 2013-03-01 | $46.00K 10-K · filed 2013-03-01 | |
| 2010-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $20.00K 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | $5.00K 10-Q · filed 2011-08-12 | |||
| 2009-12-31 | $17.00K 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |